IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.
| Revenue (Most Recent Fiscal Year) | $36.15M |
| Net Income (Most Recent Fiscal Year) | $-7.04M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.13 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.65 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -29.52% |
| Net Margin (Trailing 12 Months) | -25.55% |
| Return on Equity (Trailing 12 Months) | -129.86% |
| Return on Assets (Trailing 12 Months) | -23.63% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.70 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.59 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.10 |
| Inventory Turnover (Trailing 12 Months) | 6.39 |
| Book Value per Share (Most Recent Fiscal Quarter) | $4.55 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.30 |
| Earnings per Share (Most Recent Fiscal Year) | $-3.30 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.41 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 2.23M |
| Free Float | 2.10M |
| Market Capitalization | $5.09M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 1.05 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 5.91% |
| Percentage Held By Institutions (Latest 13F Reports) | 7.68% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |